Matches in SemOpenAlex for { <https://semopenalex.org/work/W2788521036> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2788521036 endingPage "144" @default.
- W2788521036 startingPage "133" @default.
- W2788521036 abstract "Background: IL-17A is a founding member of the IL-17 family that has been implicated in the pathogenesis of inflammatory-associated diseases such as cancer and autoimmune disease. In cancer, IL-17A participates in many key events for tumor development, in part by affecting innate and adaptive immune system and also by direct modulation of many pro-tumor events. Moreover, IL-17A dysregulation at the site of inflammation is associated with rheumatoid arthritis, multiple sclerosis, psoriasis, among others. IL-17A has emerged as a topic of interest and is under profound investigation for its involvement in several types of inflammatory-associated diseases. Objective: This review aims to present an overview of the state of the art of IL-17A role in cancer and inflammation, as well as to describe recent patents targeting IL-17A with relevant clinical and biological properties for the prevention and treatment of cancer and inflammatory diseases. Methods: Relevant information was obtained by searching in PubMed using IL-17A or IL-17, cancer and inflammation as keywords, while relevant patents were obtained mainly from Google Patents. Results: Literature data indicated IL-17A as important biomolecule in the physiopathology of cancer and inflammatory diseases. Whereas, novel patents (2010 to 2017) targeting IL-17A are focused mainly on describing strategies to modulate IL-17A per se, co-modulation by bispecific antibodies to blocking IL-17A and important cytokines for IL-17A functions, upstream mechanisms and compounds to regulate IL-17A expression. Conclusion: The promising effects of patented agents against IL-17A may open new opportunities to therapeutic intervention targeting at different levels of involvement in the pathogenesis of cancer and inflammatory diseases. Keywords: Cancer, inflammation, interleukin-17A (IL-17A), interleukin-17 Receptor A (IL-17RA), patents, signaling, therapies." @default.
- W2788521036 created "2018-03-06" @default.
- W2788521036 creator A5005800454 @default.
- W2788521036 creator A5044571137 @default.
- W2788521036 date "2018-05-11" @default.
- W2788521036 modified "2023-10-16" @default.
- W2788521036 title "Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation" @default.
- W2788521036 doi "https://doi.org/10.2174/1574892813666180220105958" @default.
- W2788521036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29468982" @default.
- W2788521036 hasPublicationYear "2018" @default.
- W2788521036 type Work @default.
- W2788521036 sameAs 2788521036 @default.
- W2788521036 citedByCount "5" @default.
- W2788521036 countsByYear W27885210362018 @default.
- W2788521036 countsByYear W27885210362019 @default.
- W2788521036 countsByYear W27885210362021 @default.
- W2788521036 countsByYear W27885210362023 @default.
- W2788521036 crossrefType "journal-article" @default.
- W2788521036 hasAuthorship W2788521036A5005800454 @default.
- W2788521036 hasAuthorship W2788521036A5044571137 @default.
- W2788521036 hasConcept C121608353 @default.
- W2788521036 hasConcept C126322002 @default.
- W2788521036 hasConcept C156730664 @default.
- W2788521036 hasConcept C203014093 @default.
- W2788521036 hasConcept C2776914184 @default.
- W2788521036 hasConcept C2779134260 @default.
- W2788521036 hasConcept C2780564577 @default.
- W2788521036 hasConcept C47348012 @default.
- W2788521036 hasConcept C60644358 @default.
- W2788521036 hasConcept C71924100 @default.
- W2788521036 hasConcept C86803240 @default.
- W2788521036 hasConcept C8891405 @default.
- W2788521036 hasConceptScore W2788521036C121608353 @default.
- W2788521036 hasConceptScore W2788521036C126322002 @default.
- W2788521036 hasConceptScore W2788521036C156730664 @default.
- W2788521036 hasConceptScore W2788521036C203014093 @default.
- W2788521036 hasConceptScore W2788521036C2776914184 @default.
- W2788521036 hasConceptScore W2788521036C2779134260 @default.
- W2788521036 hasConceptScore W2788521036C2780564577 @default.
- W2788521036 hasConceptScore W2788521036C47348012 @default.
- W2788521036 hasConceptScore W2788521036C60644358 @default.
- W2788521036 hasConceptScore W2788521036C71924100 @default.
- W2788521036 hasConceptScore W2788521036C86803240 @default.
- W2788521036 hasConceptScore W2788521036C8891405 @default.
- W2788521036 hasIssue "2" @default.
- W2788521036 hasLocation W27885210361 @default.
- W2788521036 hasLocation W27885210362 @default.
- W2788521036 hasOpenAccess W2788521036 @default.
- W2788521036 hasPrimaryLocation W27885210361 @default.
- W2788521036 hasRelatedWork W2040164730 @default.
- W2788521036 hasRelatedWork W2254676317 @default.
- W2788521036 hasRelatedWork W2275320660 @default.
- W2788521036 hasRelatedWork W2358496962 @default.
- W2788521036 hasRelatedWork W2358500869 @default.
- W2788521036 hasRelatedWork W3031081582 @default.
- W2788521036 hasRelatedWork W3080367034 @default.
- W2788521036 hasRelatedWork W3118996049 @default.
- W2788521036 hasRelatedWork W4324045039 @default.
- W2788521036 hasRelatedWork W4383998357 @default.
- W2788521036 hasVolume "13" @default.
- W2788521036 isParatext "false" @default.
- W2788521036 isRetracted "false" @default.
- W2788521036 magId "2788521036" @default.
- W2788521036 workType "article" @default.